Alamar Biosciences Inc Cl A (ALMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Sales | 26,035 | 0 | 13,091 |
| Cost of Goods | 11,578 | N/A | 6,702 |
| Gross Profit | 14,457 | N/A | 6,389 |
| Operating Expenses | 27,382 | 0 | 15,644 |
| Operating Income | -12,347 | N/A | -8,553 |
| Interest Expense | 223 | 0 | 46 |
| Other Income | -8,291 | 0 | 940 |
| Pre-tax Income | -20,861 | 0 | -7,659 |
| Income Tax | 464 | N/A | N/A |
| Net Income Continuous | -21,325 | N/A | -7,659 |
| Net Income | $-21,325 | $N/A | $-7,659 |
| EPS Basic Total Ops | -1.74 | N/A | -0.68 |
| EPS Basic Continuous Ops | -1.74 | N/A | -0.68 |
| EPS Diluted Total Ops | -1.74 | N/A | -0.68 |
| EPS Diluted Continuous Ops | -1.74 | N/A | -0.68 |
| EPS Diluted Before Non-Recurring Items | -1.74 | N/A | N/A |
| EBITDA(a) | $-11,113 | $N/A | $-7,831 |